"The tumor network makes glioblastomas so difficult to fight: they cannot be completely removed and their interconnection makes them almost insensitive to radiation and chemotherapy," says ...

Bypassing the blood-brain barrier (BBB) has been one of the greatest hurdles in the development of treatments for patients ...

MSD has acquired Yale University spinout Modifi Biosciences, claiming ownership of a potential new class of therapeutics for difficult-to-treat brain tumours, including glioblastomas. Under the ...